Table 1 Patient eligibility criteria

Inclusion criteria

• Ability to provide written informed consent

• Diagnosis with an infrarenal AAA measuring a maximum diameter ≥ 30 mm based on CT or ultrasound

• No current indication for AAA repair according to the treating physician or expectation that this will be revised over 12 months

• High likelihood of treatment compliance over 12 months according to the treating physician and local study coordinator

• Aged ≥ 50 years

Exclusion criteria

• Symptomatic, ruptured or mycotic AAA

• Contraindication to the study protocol:

○ Previous reaction to myo-inositol supplementation

○ Inability to tolerate abdominal imaging

○ Inability to provide blood samples for safety and outcome analysis

• Previous abdominal aortic surgery

• Current or planned participation in another randomised trial

• Treating physician feels the patient is not suitable for trial entry